- Blexten Canadian Prescriptions Increased 21% Year-Over-Year - - Suvexx Canadian Prescriptions Increased 120% Year-Over-Year - Miravo to Hold Virtual Annual Meeting May 16th at 9:00 a.m. ET MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals I
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced that data from
FORT LAUDERDALE, Fla. & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today the appointment
Quarterly Revenue of $123 Million, an Increase of 43% YoY Gross Profit of $57 Million, an Increase of 68% YoY Gross Margin of 46%, an Increase of 676bps YoY, 149bps QoQ Over Prior Adjusted Gross Margin1 Adjusted EBITDA of $17 Million, an Increase of 3
Lead AMHR2 agonist compound demonstrates high specific activity in biological assays and desired pharmacokinetic profile in preclinical animal studies NEW YORK--(BUSINESS WIRE)--Celmatix Inc. a biotechnology company focused on ovarian biology, today anno
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) ("AGI" or the "Company") is pleased to announce the voting results from its annual meeting of shareholders held on May 13, 2022. A total of 9,971,406 common shares, representing
CHAPEL HILL, N.C., TORONTO & LONDON--(BUSINESS WIRE)--#HEOR--AESARA (www.aesara.com) is pleased to announce their attendance and poster presentations this ISPOR 2022 held in Washington, D.C. from May 16 – 18, 2022. A total of six posters will be present
Appoints: Commercial Managing Director, Europe; and Chief Growth Officer BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announces the promotion of two members of its leadership team to fill newly cre
LAVAL, Quebec--(BUSINESS WIRE)--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its 2022 A
MISSISSAUGA, Ontario--(BUSINESS WIRE)--$MDX #SkinCancer--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) has announced that, in connection with the Private Placement ( the “Financing”) originally announced in its press release dated Ma
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.